Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
This compounded version is ideal for adults with significant weight loss goals who want: Enhanced metabolic support Greater appetite control Energy support alongside weight loss Sustainable, long-term results For smaller weight loss goals or maintenance, GLP-1 only medications like Semaglutide may still be appropriate
This should be a particular effect on ketamine functions given the counteracted ketamine-cognition dysfunction, counteracted social withdrawal, and counteracted anhedonia versus exerted additional anxiolytic effect [59]
Whether your goal is anti-aging, fat loss, healing, performance enhancement, or immune optimization , peptide therapy provides a safe, natural, and clinically effective pathway
no validated storage guidance exists for retatrutide as it holds no UK marketing authorisation
